Literature DB >> 23640120

Table showing dietary phosphorus/protein ratio for the Spanish population. Usefulness in chronic kidney disease.

Guillermina Barril-Cuadrado1, M Bernardita Puchulu, José A Sánchez-Tomero.   

Abstract

BACKGROUND: The K/DOQI guidelines recommend the use of phosphorus/protein food ratios for proper control of dietary phosphorus. Evidence exists from tables with phosphorus to protein ratios for common foods. No such table exists for common foods consumed by the Spanish population with ratio estimations.
OBJECTIVES: To estimate the phosphorus to protein ratio in foods commonly used by the Spanish population and to establish its usefulness in the selection of foods for patients with chronic kidney disease.
METHOD: Tables with the phosphorus to protein ratio were prepared from two data sources concerning Spanish food composition. We evaluated chemical composition per 100g of raw food. The tables do not include phosphorus additives. No foods with high ratio of phosphorus to protein were eliminated in order to allow comparisons between different foods from each group.
RESULTS: Shown in the tables.
CONCLUSIONS: The dietary prescription for patients with chronic kidney disease should take into consideration not only the absolute phosphorus value of food consumed, but also the phosphorus to protein ratio of each food and the total amount of phosphorus in the diet. The more "natural" a diet is, the more likely that the patient will reach an acceptable phosphorus to protein ratio of less than 16mg/g, which does not increase mortality. There is clearly a need for an educational program on nutrition and phosphorus sources in which food ratio tables could be a useful tool for the multidisciplinary teams caring for renal patients.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23640120     DOI: 10.3265/Nefrologia.pre2013.Feb.11918

Source DB:  PubMed          Journal:  Nefrologia        ISSN: 0211-6995            Impact factor:   2.033


  5 in total

1.  Canadian Society of Nephrology Commentary on the Kidney Disease Improving Global Outcomes 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder.

Authors:  Rachel M Holden; Reem A Mustafa; R Todd Alexander; Marisa Battistella; Micheli U Bevilacqua; Greg Knoll; Fabrice Mac-Way; Martina Reslerova; Ron Wald; Philip D Acott; Patrick Feltmate; Allan Grill; Kailash K Jindal; Meena Karsanji; Bryce A Kiberd; Sara Mahdavi; Kailee McCarron; Amber O Molnar; Maury Pinsk; Celia Rodd; Steven D Soroka; Amanda J Vinson; Deborah Zimmerman; Catherine M Clase
Journal:  Can J Kidney Health Dis       Date:  2020-08-04

2.  Potential Predictors of Plasma Fibroblast Growth Factor 23 Concentrations: Cross-Sectional Analysis in the EPIC-Germany Study.

Authors:  Romina di Giuseppe; Tilman Kühn; Frank Hirche; Brian Buijsse; Jutta Dierkes; Andreas Fritsche; Rudolf Kaaks; Heiner Boeing; Gabriele I Stangl; Cornelia Weikert
Journal:  PLoS One       Date:  2015-07-20       Impact factor: 3.240

3.  Accuracy of a Nutrient Database in Estimating the Dietary Phosphorus-to-Protein Ratio and Using a Boiling Method in Low-Phosphate Hospital Diets.

Authors:  Wan-Chuan Tsai; Yu-Sen Peng; Hon-Yen Wu; Shih-Ping Hsu; Yen-Ling Chiu; Lie-Chuan Liu; Shu-Min Tsai; Kuo-Liong Chien
Journal:  Sci Rep       Date:  2018-10-15       Impact factor: 4.379

Review 4.  The role of phosphate-containing medications and low dietary phosphorus-protein ratio in reducing intestinal phosphorus load in patients with chronic kidney disease.

Authors:  Jiameng Li; Liya Wang; Mei Han; Yuqin Xiong; Ruoxi Liao; Yupei Li; Si Sun; Anil Maharjan; Baihai Su
Journal:  Nutr Diabetes       Date:  2019-04-03       Impact factor: 5.097

5.  Dietary Assessment of Korean Non-dialysis Chronic Kidney Disease Patients with or without Diabetes.

Authors:  Hyesu Lee; Hyunsuk Kim; Tae Yeon Kim; Hyunjin Ryu; Dal Lae Ju; Miyoung Jang; Kook Hwan Oh; Curie Ahn; Sung Nim Han
Journal:  J Korean Med Sci       Date:  2020-06-15       Impact factor: 2.153

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.